News

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the ...
A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...
Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...
Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.
Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.
PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech” or the "Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and infectious ...
“We show that if you can see where a virus is evolving ahead of time, you can begin to make future-proof vaccines,” said ...